Shows
Medication TalkCardiovascular Impact of Diabetes MedsListen in as our expert panel discusses which diabetes meds have cardiovascular (CV) benefits. We’ll review the evidence and discuss the pros and cons of SGLT2 inhibitors (dapagliflozin, empagliflozin, etc) and GLP-1 agonists (dulaglutide, semaglutide, etc) in patients with or at risk for CV disease.Special Guests:Lauren G. Pamulapati, PharmD, BCACPAssociate Professor, Ambulatory CareVirginia Commonwealth University School of PharmacyClinical Pharmacist, Hayes Willis Health Center/VCU HealthChristie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCPProfessor, Pharmacy PracticeDirector, PGY2 Ambulatory Care Residency ProgramMidwestern University College of Pharmacy, Downers Grove CampusClinical Pharmacist, Northwestern MedicineTRC Editorial Adv...2025-04-0136 min
The BPS Board-Certified Pharmacist Podcast2020 BPS Seed Grant Recipients Vasyl Zbyrak and Lauren PamulapatiOn this episode, Ellie LaNou, PharmD, BCPS, is joined by 2020 BPS Seed Grant Recipients, Vasyl Zbyrak, PharmD, BCPS, and Lauren Pamulapati, PharmD, BCACP, as they detail their process to identify the factors associated with increased job satisfaction among BPS Board-Certified pharmacists in Virginia. They discuss how this topic became of interest and the broader applications of the information they found in the current pharmacy landscape.
For any questions about the seed grant process, board certification, or other ways BPS supports research into board certification, you can visit the BPS website at www.BPSweb.org. Until next time!2022-07-1127 min